Financial - Conglomerates
Compare Stocks
4 / 10Stock Comparison
PACS vs ADUS vs ENSG vs NHC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
PACS vs ADUS vs ENSG vs NHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Financial - Conglomerates | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $5.27B | $1.81B | $10.18B | $2.66B |
| Revenue (TTM) | $5.29B | $1.45B | $5.27B | $1.50B |
| Net Income (TTM) | $192M | $100M | $363M | $101M |
| Gross Margin | 21.9% | 32.5% | 15.2% | 38.5% |
| Operating Margin | 5.9% | 9.8% | 8.5% | 8.1% |
| Forward P/E | 16.2x | 14.1x | 23.2x | 21.5x |
| Total Debt | $3.20B | $209M | $4.15B | $87M |
| Cash & Equiv. | $197M | $82M | $504M | — |
PACS vs ADUS vs ENSG vs NHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 24 | May 26 | Return |
|---|---|---|---|
| PACS Group, Inc. (PACS) | 100 | 134.6 | +34.6% |
| Addus HomeCare Corp… (ADUS) | 100 | 101.2 | +1.2% |
| The Ensign Group, I… (ENSG) | 100 | 147.3 | +47.3% |
| National HealthCare… (NHC) | 100 | 188.6 | +88.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PACS vs ADUS vs ENSG vs NHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PACS has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 29.3%, EPS growth 221.1%
- 29.3% NII/revenue growth vs NHC's 13.2%
- +219.6% vs ADUS's -13.4%
ADUS is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.58, Low D/E 19.2%, current ratio 1.80x
- PEG 0.70 vs ENSG's 1.68
- Lower P/E (14.1x vs 21.5x), PEG 0.70 vs 0.93
- 7.0% ROA vs PACS's 3.4%, ROIC 8.8% vs 5.6%
ENSG is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- 7.5% 10Y total return vs NHC's 198.2%
- Beta 0.42, yield 0.1%, current ratio 1.42x
- 6.9% margin vs PACS's 3.6%
NHC is the clearest fit if your priority is dividends.
- 1.4% yield, 12-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.3% NII/revenue growth vs NHC's 13.2% | |
| Value | Lower P/E (14.1x vs 21.5x), PEG 0.70 vs 0.93 | |
| Quality / Margins | 6.9% margin vs PACS's 3.6% | |
| Stability / Safety | Beta 0.42 vs PACS's 0.64, lower leverage | |
| Dividends | 1.4% yield, 12-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +219.6% vs ADUS's -13.4% | |
| Efficiency (ROA) | 7.0% ROA vs PACS's 3.4%, ROIC 8.8% vs 5.6% |
PACS vs ADUS vs ENSG vs NHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PACS vs ADUS vs ENSG vs NHC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ADUS leads in 2 of 6 categories
NHC leads 2 • PACS leads 0 • ENSG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ENSG and NHC each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PACS is the larger business by revenue, generating $5.3B annually — 3.7x ADUS's $1.4B. Profitability is closely matched — net margins range from 6.9% (ENSG) to 3.6% (PACS). On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $5.3B | $1.4B | $5.3B | $1.5B |
| EBITDAEarnings before interest/tax | $365M | $159M | $558M | $166M |
| Net IncomeAfter-tax profit | $192M | $100M | $363M | $101M |
| Free Cash FlowCash after capex | $254M | $137M | $406M | $147M |
| Gross MarginGross profit ÷ Revenue | +21.9% | +32.5% | +15.2% | +38.5% |
| Operating MarginEBIT ÷ Revenue | +5.9% | +9.8% | +8.5% | +8.1% |
| Net MarginNet income ÷ Revenue | +3.6% | +6.9% | +6.9% | +6.7% |
| FCF MarginFCF ÷ Revenue | — | +9.5% | +7.7% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +7.7% | +18.4% | +12.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +75.0% | +17.2% | +21.9% | -8.4% |
Valuation Metrics
ADUS leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 18.7x trailing earnings, ADUS trades at a 37% valuation discount to ENSG's 29.8x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $5.3B | $1.8B | $10.2B | $2.7B |
| Enterprise ValueMkt cap + debt − cash | $8.3B | $1.9B | $13.8B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | 27.56x | 18.67x | 29.85x | 22.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.24x | 14.12x | 23.19x | 21.51x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.93x | 2.16x | 0.97x |
| EV / EBITDAEnterprise value multiple | 22.63x | 12.52x | 25.71x | 15.85x |
| Price / SalesMarket cap ÷ Revenue | 1.00x | 1.28x | 2.01x | 1.81x |
| Price / BookPrice ÷ Book value/share | 5.53x | 1.65x | 4.59x | 2.50x |
| Price / FCFMarket cap ÷ FCF | — | 17.48x | 27.46x | 17.89x |
Profitability & Efficiency
ADUS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
PACS delivers a 20.1% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $9 for ADUS. NHC carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to PACS's 3.36x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs NHC's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.1% | +9.3% | +16.6% | +9.6% |
| ROA (TTM)Return on assets | +3.4% | +7.0% | +6.8% | +6.4% |
| ROICReturn on invested capital | +5.6% | +8.8% | +7.0% | +8.4% |
| ROCEReturn on capital employed | +7.0% | +10.9% | +10.2% | — |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 | 2 |
| Debt / EquityFinancial leverage | 3.36x | 0.19x | 1.86x | 0.08x |
| Net DebtTotal debt minus cash | $3.0B | $127M | $3.7B | $87M |
| Cash & Equiv.Liquid assets | $197M | $82M | $504M | — |
| Total DebtShort + long-term debt | $3.2B | $209M | $4.2B | $87M |
| Interest CoverageEBIT ÷ Interest expense | — | 14.45x | 88.33x | 24.41x |
Total Returns (Dividends Reinvested)
NHC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHC five years ago would be worth $26,213 today (with dividends reinvested), compared to $10,002 for ADUS. Over the past 12 months, PACS leads with a +219.6% total return vs ADUS's -13.4%. The 3-year compound annual growth rate (CAGR) favors NHC at 46.5% vs ADUS's 5.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.9% | -8.7% | +0.3% | +31.9% |
| 1-Year ReturnPast 12 months | +219.6% | -13.4% | +27.5% | +81.9% |
| 3-Year ReturnCumulative with dividends | +46.2% | +16.3% | +88.9% | +214.6% |
| 5-Year ReturnCumulative with dividends | +46.2% | +0.0% | +103.2% | +162.1% |
| 10-Year ReturnCumulative with dividends | +46.2% | +399.9% | +752.0% | +198.2% |
| CAGR (3Y)Annualised 3-year return | +13.5% | +5.2% | +23.6% | +46.5% |
Risk & Volatility
Evenly matched — ENSG and NHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than PACS's 0.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHC currently trades 93.1% from its 52-week high vs PACS's 78.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 0.58x | 0.42x | 0.60x |
| 52-Week HighHighest price in past year | $43.08 | $124.44 | $218.00 | $184.08 |
| 52-Week LowLowest price in past year | $7.50 | $90.89 | $133.81 | $93.54 |
| % of 52W HighCurrent price vs 52-week peak | +78.0% | +78.2% | +80.0% | +93.1% |
| RSI (14)Momentum oscillator 0–100 | 48.9 | 49.3 | 23.3 | 51.2 |
| Avg Volume (50D)Average daily shares traded | 772K | 236K | 358K | 117K |
Analyst Outlook
NHC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PACS as "Buy", ADUS as "Buy", ENSG as "Buy". Consensus price targets imply 32.9% upside for PACS (target: $45) vs 27.6% for ENSG (target: $222). For income investors, NHC offers the higher dividend yield at 1.44% vs ENSG's 0.14%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | — |
| Price TargetConsensus 12-month target | $44.67 | $128.67 | $222.33 | — |
| # AnalystsCovering analysts | 8 | 15 | 13 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.1% | +1.4% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 12 | 12 |
| Dividend / ShareAnnual DPS | — | — | $0.24 | $2.47 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | +0.6% |
ADUS leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). NHC leads in 2 (Total Returns, Analyst Outlook). 2 tied.
PACS vs ADUS vs ENSG vs NHC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PACS or ADUS or ENSG or NHC a better buy right now?
For growth investors, PACS Group, Inc.
(PACS) is the stronger pick with 29. 3% revenue growth year-over-year, versus 13. 2% for National HealthCare Corporation (NHC). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate PACS Group, Inc. (PACS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PACS or ADUS or ENSG or NHC?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.
7x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PACS or ADUS or ENSG or NHC?
Over the past 5 years, National HealthCare Corporation (NHC) delivered a total return of +162.
1%, compared to +0. 0% for Addus HomeCare Corporation (ADUS). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus PACS's +46. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PACS or ADUS or ENSG or NHC?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus PACS Group, Inc. 's 0. 64β — meaning PACS is approximately 52% more volatile than ENSG relative to the S&P 500. On balance sheet safety, National HealthCare Corporation (NHC) carries a lower debt/equity ratio of 8% versus 3% for PACS Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PACS or ADUS or ENSG or NHC?
By revenue growth (latest reported year), PACS Group, Inc.
(PACS) is pulling ahead at 29. 3% versus 13. 2% for National HealthCare Corporation (NHC). On earnings-per-share growth, the picture is similar: PACS Group, Inc. grew EPS 221. 1% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PACS or ADUS or ENSG or NHC?
National HealthCare Corporation (NHC) is the more profitable company, earning 8.
2% net margin versus 3. 6% for PACS Group, Inc. — meaning it keeps 8. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 5. 9% for PACS. At the gross margin level — before operating expenses — NHC leads at 37. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PACS or ADUS or ENSG or NHC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 1x forward P/E versus 23. 2x for The Ensign Group, Inc. — 9. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PACS: 32. 9% to $44. 67.
08Which pays a better dividend — PACS or ADUS or ENSG or NHC?
In this comparison, NHC (1.
4% yield), ENSG (0. 1% yield) pay a dividend. PACS, ADUS do not pay a meaningful dividend and should not be held primarily for income.
09Is PACS or ADUS or ENSG or NHC better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, PACS: +46. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PACS and ADUS and ENSG and NHC?
These companies operate in different sectors (PACS (Financial Services) and ADUS (Healthcare) and ENSG (Healthcare) and NHC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PACS is a small-cap high-growth stock; ADUS is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; NHC is a small-cap quality compounder stock. NHC pays a dividend while PACS, ADUS, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.